Related Experiment Video
Updated: Jul 27, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT
Vivian Vij1, Ignacio Cruz-González2, Roberto Galea3
1Department of Cardiology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Insights
Device-related thrombus (DRT) after left atrial appendage closure (LAAC) poses a significant risk for stroke or systemic embolism (SE). Identifying predictors for these events in DRT patients is crucial for improving patient outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Thrombosis Research
Background:
- Device-related thrombus (DRT) following left atrial appendage closure (LAAC) is linked to adverse events like ischemic stroke and systemic embolism (SE).
- Limited data exists on the predictors of stroke/SE specifically in patients who develop DRT after LAAC.
Purpose of the Study:
- To identify predisposing factors for stroke/SE in patients diagnosed with DRT after LAAC.
- To analyze the temporal relationship between stroke/SE events and the diagnosis of DRT.
Main Methods:
- The EUROC-DRT registry, comprising 176 patients with DRT post-LAAC, was analyzed.
- Patients with symptomatic DRT (stroke/SE occurring with DRT diagnosis) were compared to those with asymptomatic DRT.
- Baseline characteristics, anti-thrombotic strategies, device positioning, and event timing were assessed.
Main Results:
- 14.2% of patients (25/176) with DRT experienced stroke/SE (symptomatic DRT).
- Stroke/SE occurred at a median of 198 days post-LAAC, with 45.8% occurring within one month of DRT diagnosis.
- Symptomatic DRT patients showed lower ejection fractions and higher rates of non-paroxysmal atrial fibrillation; event timing varied, and occurred across different anti-thrombotic regimens.
Conclusions:
- Stroke/SE events in DRT patients occur both temporally related to DRT diagnosis and independently.
- Identifying specific risk factors for stroke/SE in DRT patients remains challenging, indicating a substantial risk for all such patients.
- Further research is needed to develop strategies for minimizing the risk of DRT and subsequent ischemic events.
Background:
Device-related thrombus (DRT) after left atrial appendage closure (LAAC) is associated with adverse outcomes, i.e. ischemic stroke or systemic embolism (SE). Data on predictors of stroke/SE in the context of DRT are limited.
Aims:
This study aimed to identify predisposing factors for stroke/SE in DRT patients. In addition, the temporal connection of stroke/SE to DRT diagnosis was analyzed.
Methods:
The EUROC-DRT registry included 176 patients, in whom DRT after LAAC were diagnosed. Patients with symptomatic DRT, defined as stroke/SE in the context of DRT diagnosis, were compared against patients with non-symptomatic DRT. Baseline characteristics, anti-thrombotic regimens, device position, and timing of stroke/SE were compared.
Results:
Stroke/SE occurred in 25/176 (14.2%) patients diagnosed with DRT (symptomatic DRT). Stroke/SE occurred after a median of 198 days (IQR 37-558) after LAAC. In 45.8% stroke/SE occurred within one month before/after DRT diagnosis (DRT-related stroke). Patients with symptomatic DRT had lower left ventricular ejection fractions (50.0 ± 9.1% vs. 54.2 ± 11.0%, p = 0.03) and higher rates of non-paroxysmal atrial fibrillation (84.0% vs. 64.9%, p = 0.06). Other baseline parameters and device positions were not different. Most ischemic events occurred among patients with single antiplatelet therapy (50%), however, stroke/SE was also observed under dual antiplatelet therapy (25%) or oral anticoagulation (20%).
Conclusion:
Stroke/SE are documented in 14.2% and occur both in close temporal relation to the DRT finding and chronologically independently therefrom. Identification of risk factors remains cumbersome, putting all DRT patients at substantial risk for stroke/SE. Further studies are necessary to minimize the risk of DRT and ischemic events.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies

